Fields of interest:
Mechanistic and Environmental Toxicology and Evidence-based Medicine
Mohammad Abdollahi (MA) obtained his PharmD in 1988 from University of Tehran and his PhD in Pharmacology and Toxicology from Tehran University of Medical Sciences (TUMS) in 1994, and a postdoc fellowship in Biochemical/Molecular Toxicology from University of Toronto in 2001. MA obtained full professor honorship of TUMS in 2003. MA has supervised more than 300 graduate and postgraduate students. MA has published more than 600 high-impact full papers and contributed in 26 books from famed publishers with more than 12000 citations. MA is involved in many editorial activities such as being a chief editor to two medical and pharmaceutical journals published by Elsevier and Springer BMC. MA cooperates with some key international organisations such as COPE (Committee on Publication Ethics) as a Council Trustee Member in UK, OPCW (Organisation for Prohibition of Chemical Weapons) as a Scientific Advisory Board in Netherlands, WHO (World Health Organisation) as a Member of Guideline Developing Group for Prevention of Lead Poisoning in Switzerland, IAS (Islamic-World Academy of Sciences) as a Fellow and IAS-COMSTECH Laureate in Pharmacology & Toxicology, WLT (World Library of Toxicology) as a country correspondent, BMC Advisory Grou, and some others. The main research interests of MA is Mechanistic and Environmental Toxicology, and Evidence-Based Medicine. MA’s contributions to this field is attested to by an extensive array of citations in papers and books. MA has uncovered critical mechanistic connections between the toxicity of chemicals and the etiology of human diseases. One of the research interests of MA is the mechanisms relating chronic exposure to toxic compounds and the induction of debilitating human diseases. To promote this idea, MA established a multitude of in vivo and in vitro models, and carried out mechanistic studies in the field of toxicology and disease biomarkers. He is one of the pioneers in the field of oxidative stress, a toxicological mechanism which plays a role in many human debilitating diseases. One of MA’s theories is that synergistic effects of natural or synthetic compounds, with anti-oxidative effects, and formulating such mixtures may result in protection against diabetes and human inflammatory bowel disease, and also diminishing toxicity of xenobiotics. Now MA is elucidating the elements and mechanisms that are involved in such relationship. Studies of MA give the hope that new drugs with natural origin in synergistic effects would control some oxidant-related phenomenon like age-related disorders.
Links to the profile in Google Scholar and ResearcherID